Agilent Technologies Pre-Tax Profit Margin 2012-2025 | A
Current and historical pre-tax profit margin for Agilent Technologies (A) from 2012 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Agilent Technologies pre-tax profit margin for the three months ending October 31, 2025 was .
| Agilent Technologies Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2025-10-31 | $6.95B | $1.44B | 20.65% |
| 2025-07-31 | $6.79B | $1.39B | 20.54% |
| 2025-04-30 | $6.63B | $1.37B | 20.68% |
| 2025-01-31 | $6.53B | $1.49B | 22.73% |
| 2024-10-31 | $6.51B | $1.52B | 23.36% |
| 2024-07-31 | $6.50B | $1.54B | 23.70% |
| 2024-04-30 | $6.59B | $1.33B | 20.16% |
| 2024-01-31 | $6.74B | $1.33B | 19.78% |
| 2023-10-31 | $6.83B | $1.34B | 19.60% |
| 2023-07-31 | $6.99B | $1.37B | 19.65% |
| 2023-04-30 | $7.04B | $1.64B | 23.28% |
| 2023-01-31 | $6.93B | $1.60B | 23.02% |
| 2022-10-31 | $6.85B | $1.50B | 21.96% |
| 2022-07-31 | $6.66B | $1.50B | 22.48% |
| 2022-04-30 | $6.53B | $1.43B | 21.86% |
| 2022-01-31 | $6.45B | $1.37B | 21.21% |
| 2021-10-31 | $6.32B | $1.36B | 21.52% |
| 2021-07-31 | $6.14B | $1.20B | 19.46% |
| 2021-04-30 | $5.82B | $1.09B | 18.69% |
| 2021-01-31 | $5.53B | $0.94B | 16.91% |
| 2020-10-31 | $5.34B | $0.84B | 15.77% |
| 2020-07-31 | $5.22B | $0.79B | 15.13% |
| 2020-04-30 | $5.24B | $0.79B | 15.15% |
| 2020-01-31 | $5.24B | $0.89B | 17.00% |
| 2019-10-31 | $5.16B | $0.92B | 17.80% |
| 2019-07-31 | $5.09B | $0.93B | 18.31% |
| 2019-04-30 | $5.02B | $0.95B | 18.97% |
| 2019-01-31 | $4.99B | $0.96B | 19.27% |
| 2018-10-31 | $4.91B | $0.95B | 19.25% |
| 2018-07-31 | $4.81B | $0.93B | 19.30% |
| 2018-04-30 | $4.72B | $0.88B | 18.62% |
| 2018-01-31 | $4.62B | $0.84B | 18.26% |
| 2017-10-31 | $4.47B | $0.80B | 17.96% |
| 2017-07-31 | $4.39B | $0.73B | 16.57% |
| 2017-04-30 | $4.32B | $0.67B | 15.47% |
| 2017-01-31 | $4.24B | $0.60B | 14.03% |
| 2016-10-31 | $4.20B | $0.54B | 12.95% |
| 2016-07-31 | $4.13B | $0.54B | 12.99% |
| 2016-04-30 | $4.10B | $0.53B | 12.94% |
| 2016-01-31 | $4.04B | $0.51B | 12.60% |
| 2015-10-31 | $4.04B | $0.48B | 11.89% |
| 2015-07-31 | $4.81B | $0.42B | 8.78% |
| 2015-04-30 | $4.80B | $0.38B | 7.89% |
| 2015-01-31 | $4.83B | $0.35B | 7.29% |
| 2014-10-31 | $4.81B | $0.34B | 6.99% |
| 2014-07-31 | $4.72B | $0.51B | 10.69% |
| 2014-04-30 | $5.37B | $0.63B | 11.78% |
| 2014-01-31 | $6.11B | $0.76B | 12.45% |
| 2013-10-31 | $6.78B | $0.86B | 12.67% |
| 2013-07-31 | $6.83B | $0.86B | 12.60% |
| 2013-04-30 | $6.90B | $0.89B | 12.85% |
| 2013-01-31 | $6.90B | $0.98B | 14.23% |
| 2012-10-31 | $6.86B | $1.04B | 15.21% |
| 2012-07-31 | $6.82B | $1.08B | 15.84% |
| 2012-04-30 | $6.79B | $1.12B | 16.55% |
| 2012-01-31 | $6.73B | $1.09B | 16.19% |
| 2011-10-31 | $6.62B | $1.03B | 15.60% |
| 2011-07-31 | $6.46B | $0.98B | 15.19% |
| 2011-04-30 | $6.16B | $0.93B | 15.07% |
| 2011-01-31 | $5.75B | $0.81B | 14.03% |
| 2010-10-31 | $5.44B | $0.69B | 12.71% |
| 2010-07-31 | $5.04B | $0.53B | 10.49% |
| 2010-04-30 | $4.71B | $0.26B | 5.52% |
| 2010-01-31 | $4.53B | $0.06B | 1.39% |
| 2009-10-31 | $4.48B | $0.01B | 0.16% |
| 2009-07-31 | $4.80B | $0.19B | 3.86% |
| 2009-04-30 | $5.18B | $0.44B | 8.51% |
| 2009-01-31 | $5.55B | $0.70B | 12.53% |
| 2008-10-31 | $5.77B | $0.82B | 14.11% |
| 2008-07-31 | $5.74B | $0.76B | 13.23% |
| 2008-04-30 | $5.67B | $0.73B | 12.95% |
| 2008-01-31 | $5.53B | $0.69B | 12.54% |
| 2007-10-31 | $5.42B | $0.67B | 12.36% |
| 2007-07-31 | $5.30B | $0.64B | 12.11% |
| 2007-04-30 | $5.17B | $0.68B | 13.14% |
| 2007-01-31 | $5.09B | $0.67B | 13.11% |
| 2006-10-31 | $4.97B | $0.63B | 12.61% |
| 2006-07-31 | $4.60B | $0.57B | 12.40% |
| 2006-04-30 | $4.60B | $0.40B | 8.76% |
| 2006-01-31 | $4.64B | $0.32B | 6.81% |
| 2005-10-31 | $4.69B | $0.29B | 6.21% |
| 2005-07-31 | $5.07B | $0.26B | 5.15% |
| 2005-04-30 | $5.71B | $0.33B | 5.85% |
| 2005-01-31 | $6.26B | $0.41B | 6.47% |
| 2004-10-31 | $6.70B | $0.43B | 6.42% |
| 2004-07-31 | $7.03B | $0.42B | 5.99% |
| 2004-04-30 | $6.65B | $0.10B | 1.46% |
| 2004-01-31 | $6.29B | $-0.36B | -5.65% |
| 2003-10-31 | $6.06B | $-0.69B | -11.39% |
| 2003-07-31 | $6.12B | $-1.14B | -18.65% |
| 2003-04-30 | $6.01B | $-1.37B | -22.86% |
| 2003-01-31 | $6.00B | $-1.38B | -22.95% |
| 2002-10-31 | $6.01B | $-1.55B | -25.74% |
| 2002-07-31 | $5.88B | $-1.88B | -31.90% |
| 2002-04-30 | $6.31B | $-1.75B | -27.73% |
| 2002-01-31 | $7.26B | $-1.21B | -16.69% |
| 2001-10-31 | $8.40B | $-0.48B | -5.68% |
| 2001-07-31 | $10.16B | $0.69B | 6.83% |
| 2001-04-30 | $10.69B | $1.21B | 11.28% |
| 2001-01-31 | $10.43B | $1.21B | 11.57% |
| 2000-10-31 | $10.11B | $1.10B | 10.86% |
| 2000-07-31 | $9.19B | $3.08B | 33.50% |
| 2000-04-30 | $8.92B | $3.07B | 34.39% |
| 2000-01-31 | $8.79B | $3.10B | 35.25% |
| 1999-10-31 | $8.33B | $4.68B | 56.21% |
| 1999-07-31 | $7.87B | $4.22B | 53.65% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $38.508B | $6.948B |
| Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $210.647B | 24.28 |
| EssilorLuxottica (ESLOY) | France | $144.389B | 0.00 |
| Stryker (SYK) | United States | $137.523B | 27.31 |
| Boston Scientific (BSX) | United States | $135.199B | 30.92 |
| Medtronic (MDT) | Ireland | $126.407B | 17.51 |
| Medline (MDLN) | United States | $58.001B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.030B | 0.00 |
| ResMed (RMD) | United States | $36.951B | 25.58 |
| GE HealthCare Technologies (GEHC) | United States | $35.909B | 17.17 |
| Koninklijke Philips (PHG) | Netherlands | $27.434B | 17.92 |
| Insulet (PODD) | United States | $19.996B | 62.06 |
| Terumo (TRUMY) | Japan | $19.854B | 22.35 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.202B | 10.73 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.668B | 0.00 |
| Baxter (BAX) | United States | $9.962B | 8.04 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.437B | 30.34 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.369B | 13.31 |
| Envista Holdings (NVST) | United States | $4.002B | 22.96 |
| BillionToOne (BLLN) | United States | $3.934B | 0.00 |
| ICU Medical (ICUI) | United States | $3.783B | 24.02 |
| Haemonetics (HAE) | United States | $3.281B | 14.60 |
| Prestige Consumer Healthcare (PBH) | United States | $3.114B | 14.20 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.223B | 14.29 |
| Perrigo (PRGO) | Ireland | $2.077B | 5.20 |
| Neogen (NEOG) | United States | $2.034B | 44.52 |
| LeMaitre Vascular (LMAT) | United States | $1.946B | 39.18 |
| AtriCure (ATRC) | United States | $1.910B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.683B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.665B | 16.63 |
| Green Thumb Industries (GTBIF) | United States | $1.620B | 71.00 |
| AdaptHealth (AHCO) | United States | $1.408B | 20.39 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.398B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.342B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.192B | 353.71 |
| Capricor Therapeutics (CAPR) | United States | $1.106B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.019B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.959B | 0.00 |
| InMode (INMD) | Israel | $0.874B | 9.87 |
| Omeros (OMER) | United States | $0.869B | 0.00 |
| Valneva SE (VALN) | France | $0.841B | 0.00 |
| CeriBell (CBLL) | United States | $0.796B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.568B | 15.40 |
| Cerus (CERS) | United States | $0.476B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.454B | 0.00 |
| Brainsway (BWAY) | Israel | $0.433B | 73.77 |
| Cresco Labs (CRLBF) | United States | $0.429B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.424B | 0.00 |
| SNDL (SNDL) | Canada | $0.415B | 0.00 |
| Evolus (EOLS) | United States | $0.328B | 0.00 |
| Quanterix (QTRX) | United States | $0.328B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.278B | 22.12 |
| TriSalus Life Sciences (TLSI) | United States | $0.263B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.237B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.235B | 138.00 |
| TerrAscend (TSNDF) | Canada | $0.228B | 0.00 |
| High Tide (HITI) | Canada | $0.224B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Organigram Global (OGI) | Canada | $0.216B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.196B | 17.32 |
| Sanara MedTech (SMTI) | United States | $0.194B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.186B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.178B | 0.00 |
| Accendra Health (ACH) | United States | $0.170B | 1.71 |
| Quipt Home Medical (QIPT) | United States | $0.158B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.154B | 0.00 |
| Apyx Medical (APYX) | United States | $0.147B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.140B | 0.00 |
| Fonar (FONR) | United States | $0.116B | 16.87 |
| MacroGenics (MGNX) | United States | $0.111B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.110B | 0.00 |
| Exagen (XGN) | United States | $0.107B | 0.00 |
| Biote (BTMD) | United States | $0.103B | 4.52 |
| Sharps Technology (STSS) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 25.08 |
| Nephros (NEPH) | United States | $0.053B | 38.00 |
| Rockwell Medical (RMTI) | United States | $0.050B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.043B | 0.00 |
| Veru (VERU) | United States | $0.041B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 14.93 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Jin Medical (ZJYL) | China | $0.021B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |